469 related articles for article (PubMed ID: 30478724)
1. Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease.
Imai T; Inoue R; Kawada Y; Morita Y; Inatomi O; Nishida A; Bamba S; Kawahara M; Andoh A
J Gastroenterol; 2019 Feb; 54(2):149-159. PubMed ID: 30478724
[TBL] [Abstract][Full Text] [Related]
2. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
[TBL] [Abstract][Full Text] [Related]
3. Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders.
Teofani A; Marafini I; Laudisi F; Pietrucci D; Salvatori S; Unida V; Biocca S; Monteleone G; Desideri A
Nutrients; 2022 Jan; 14(2):. PubMed ID: 35057440
[TBL] [Abstract][Full Text] [Related]
4. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
Nishino K; Nishida A; Inoue R; Kawada Y; Ohno M; Sakai S; Inatomi O; Bamba S; Sugimoto M; Kawahara M; Naito Y; Andoh A
J Gastroenterol; 2018 Jan; 53(1):95-106. PubMed ID: 28852861
[TBL] [Abstract][Full Text] [Related]
5. Fungal microbiota dysbiosis in IBD.
Sokol H; Leducq V; Aschard H; Pham HP; Jegou S; Landman C; Cohen D; Liguori G; Bourrier A; Nion-Larmurier I; Cosnes J; Seksik P; Langella P; Skurnik D; Richard ML; Beaugerie L
Gut; 2017 Jun; 66(6):1039-1048. PubMed ID: 26843508
[TBL] [Abstract][Full Text] [Related]
6. A microbial signature for Crohn's disease.
Pascal V; Pozuelo M; Borruel N; Casellas F; Campos D; Santiago A; Martinez X; Varela E; Sarrabayrouse G; Machiels K; Vermeire S; Sokol H; Guarner F; Manichanh C
Gut; 2017 May; 66(5):813-822. PubMed ID: 28179361
[TBL] [Abstract][Full Text] [Related]
7. Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease.
Hoarau G; Mukherjee PK; Gower-Rousseau C; Hager C; Chandra J; Retuerto MA; Neut C; Vermeire S; Clemente J; Colombel JF; Fujioka H; Poulain D; Sendid B; Ghannoum MA
mBio; 2016 Sep; 7(5):. PubMed ID: 27651359
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Flagellin-Specific Adaptive Immunity Reveals Links to Dysbiosis in Patients With Inflammatory Bowel Disease.
Cook L; Lisko DJ; Wong MQ; Garcia RV; Himmel ME; Seidman EG; Bressler B; Levings MK; Steiner TS
Cell Mol Gastroenterol Hepatol; 2020; 9(3):485-506. PubMed ID: 31790809
[TBL] [Abstract][Full Text] [Related]
9. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
[TBL] [Abstract][Full Text] [Related]
10. The gut mycobiome of the Human Microbiome Project healthy cohort.
Nash AK; Auchtung TA; Wong MC; Smith DP; Gesell JR; Ross MC; Stewart CJ; Metcalf GA; Muzny DM; Gibbs RA; Ajami NJ; Petrosino JF
Microbiome; 2017 Nov; 5(1):153. PubMed ID: 29178920
[TBL] [Abstract][Full Text] [Related]
11. Inter-kingdom relationships in Crohn's disease explored using a multi-omics approach.
Frau A; Ijaz UZ; Slater R; Jonkers D; Penders J; Campbell BJ; Kenny JG; Hall N; Lenzi L; Burkitt MD; Pierik M; Darby AC; Probert CSJ
Gut Microbes; 2021; 13(1):1930871. PubMed ID: 34241567
[TBL] [Abstract][Full Text] [Related]
12. Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.
Hong G; Li Y; Yang M; Li G; Qian W; Xiong H; Bai T; Song J; Zhang L; Hou X
Neurogastroenterol Motil; 2020 Nov; 32(11):e13891. PubMed ID: 32449259
[TBL] [Abstract][Full Text] [Related]
13. Enteric Virome and Bacterial Microbiota in Children With Ulcerative Colitis and Crohn Disease.
Fernandes MA; Verstraete SG; Phan TG; Deng X; Stekol E; LaMere B; Lynch SV; Heyman MB; Delwart E
J Pediatr Gastroenterol Nutr; 2019 Jan; 68(1):30-36. PubMed ID: 30169455
[TBL] [Abstract][Full Text] [Related]
14. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.
Shaw KA; Bertha M; Hofmekler T; Chopra P; Vatanen T; Srivatsa A; Prince J; Kumar A; Sauer C; Zwick ME; Satten GA; Kostic AD; Mulle JG; Xavier RJ; Kugathasan S
Genome Med; 2016 Jul; 8(1):75. PubMed ID: 27412252
[TBL] [Abstract][Full Text] [Related]
15. Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission.
Pisani A; Rausch P; Bang C; Ellul S; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
Microbiol Spectr; 2022 Jun; 10(3):e0061622. PubMed ID: 35532243
[TBL] [Abstract][Full Text] [Related]
16. Fungal dysbiosis predicts the diagnosis of pediatric Crohn's disease.
El Mouzan MI; Korolev KS; Al Mofarreh MA; Menon R; Winter HS; Al Sarkhy AA; Dowd SE; Al Barrag AM; Assiri AA
World J Gastroenterol; 2018 Oct; 24(39):4510-4516. PubMed ID: 30356965
[TBL] [Abstract][Full Text] [Related]
17. Partners of patients with ulcerative colitis exhibit a biologically relevant dysbiosis in fecal microbial metacommunities.
Chen GL; Zhang Y; Wang WY; Ji XL; Meng F; Xu PS; Yang NM; Ye FQ; Bo XC
World J Gastroenterol; 2017 Jul; 23(25):4624-4631. PubMed ID: 28740351
[TBL] [Abstract][Full Text] [Related]
18. Persistent Diarrhea in Patients With Crohn's Disease After Mucosal Healing Is Associated With Lower Diversity of the Intestinal Microbiome and Increased Dysbiosis.
Boland K; Bedrani L; Turpin W; Kabakchiev B; Stempak J; Borowski K; Nguyen G; Steinhart AH; Smith MI; Croitoru K; Silverberg MS
Clin Gastroenterol Hepatol; 2021 Feb; 19(2):296-304.e3. PubMed ID: 32220613
[TBL] [Abstract][Full Text] [Related]
19. Bacterial and Fungal Profiles as Markers of Infliximab Drug Response in Inflammatory Bowel Disease.
Ventin-Holmberg R; Eberl A; Saqib S; Korpela K; Virtanen S; Sipponen T; Salonen A; Saavalainen P; Nissilä E
J Crohns Colitis; 2021 Jun; 15(6):1019-1031. PubMed ID: 33300552
[TBL] [Abstract][Full Text] [Related]
20. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
